Breaking Trump Halts Further Strikes Against Iran Amid Emerging Deal Red Sox Edge Dodgers 3-2 Behind Rafaela’s Two Home Runs Women’s Professional Baseball League Kicks Off Inaugural Season Amidst Enthusiastic Debut Pittsburgh Pirates Acquire Reliever Camilo Doval in Trade with New York Yankees Avalanche Claims Mountaineer Nirmal Purja and Fellow Climbers in Pakistan

Sunday August 2, 2026

Reporter

NanoViricides

4Articles Published

4Communities Covered

Published Articles

Press Release

NanoViricides Awaits Approval from DR Congo Regulatory Agency for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola, Financing Completed to Support the Trial

Jul 28

Press Release

NanoViricides Announces Pricing of ~$3.8 Million Registered Direct Offering

Jul 24

Press Release

As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola

Jul 23

Press Release

As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola

Jul 22